Stay updated on Cabozantinib in Salivary Gland Cancer: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.

Latest updates to the Cabozantinib in Salivary Gland Cancer: Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a small update to the site's underlying content or scripts. No substantive study information or functionality appears to be changed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays a generic error page (HTTP 500) instead of the study record content, indicating the page is temporarily unavailable.SummaryDifference18%

- Check50 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page. This indicates a new release of the study record, reflecting a minor update to the page's metadata.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page shows a new revision tag: Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor page revision/update in the site's documentation.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page shows a new Revision: v3.6.2, replacing v3.6.0. This indicates a backend or documentation version update without altering the study details.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page now shows that recruitment has ended with 'No longer looking for participants', signaling termination. It also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label along with a revision note to v3.6.0 (from v3.5.5).SummaryDifference0.6%

Stay in the know with updates to Cabozantinib in Salivary Gland Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.